Rosenblatt raised the firm’s price target on Adtran (ADTN) to $15 from $10 and keeps a Buy rating on the shares. The firm sees an “elevated probability” that Adtran can report better than modeled forecasts and grow into its valuation.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTN: